Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%, the company confirmed to Endpoints News.
CEO Ben Oakes told Endpoints by phone Wednesday morning that the move ...
↧
